Who are the technical innovators in the US? The image we often have is that of the young Silicon Valley geek or the surfing California biopharma scientist -- sometimes brash and unafraid to challenge authority and champion new and better ideas.
Biosimilars have received a lot of attention and “buzz” lately. And, as the FDA continues to...
Whatever your opinion of the FDA is you really can’t fault the agency for trying to get new...
The pharmacy that I use, a branch of one of the country’s biggest chains, has always made automated calls to some degree. Up until recently, these calls were fairly innocuous usually running along the lines of “Your prescription is ready for pick-up”. But now, they have added an interesting new wrinkle.
As I’ve gotten older it has become apparent to me that I’ve been collecting more and more prescriptions. This seems to be the trend amongst Americans – as we get older we invariably need more pills to manage our various maladies. I have reluctantly accepted this as an inevitable fact of growing older and was rather comforted that we have advanced to a point where there is a pill for everything.
Sandwiched between making medicines affordable and satisfying investors? Here’s why single use technology can drive safety and innovation in biopharmaceutical manufacturing. As someone who is deeply involved in downstream purification technologies, I have watched as the entire biopharmaceutical industry has become sandwiched between the need to deliver pharmaceuticals for less to penetrate markets and make biopharmaceuticals affordable.
Don’t you just love it when things work? When that “gadget” that you have been looking at and have researched turns out to work exactly as promoted?
A study completed by the Centers for Disease Control showed a 10 percent increase in the number of adults taking one or more prescription drugs. With more adults taking prescription drugs, the risk of child poisoning increases. Developing child-resistant packaging is more crucial than ever.
The Pharma industry is under a great deal of pressure to deliver better dividends to shareholders, and to deliver better, more effective treatment to patients at lower cost. Healthcare costs are escalating at an alarming rate and it is well reported that some of these costs are due to ineffective usage and wastage of drugs
Recently, The American Academy of Pediatrics (AAP) released new guidelines to diagnose and treat bacterial sinus infections in children. Sinus infections traditionally have been treated immediately with a 10-day course of antibiotics. Now, the AAP has come out with new guidelines that state a doctor can choose to wait up to 72 hours before writing a prescription for a child’s sinus infection.
You may have heard about a proposal that would change how leases are accounted for on corporate balance sheets. If your company leases or finances equipment, you should be aware of how the proposal could change the way you account for leases, how it potentially impacts your business, and what you can do make your voice heard on the proposal.
Cloud technology is rapidly emerging as a cost effective alternative for IT by offering scalable, robust solutions for computing, often at a fraction of the cost of more traditional software. Given the increasing adoption of technology in healthcare and rapidly growing needs for data storage and analytics, cloud technology seems ideally suited to meet many of the needs of the industry.
Let’s face it – when you were growing up – perhaps mostly in your teen years – you never really listened to your parents. You might have pretended to, or developed that uncanny ability to not really listen – yet be able to recite the last sentence of whatever was said. A great skill indeed.
Recently released reports on some currently marketed drugs have lead me to wonder if the old adage – that the treatment is worse than the disease – should be used more frequently when talking about the pharmaceutical industry - and with a “no pun intended” meaning
Last fall’s deadly meningitis outbreak linked to contaminated steroid injections is a tragic reminder of the risk of errors inherent in manual pharmacy medication compounding. Unsanitary conditions at the Massachusetts compounding pharmacy that made the injections resulted in fungal contamination of the drugs. The resulting outbreak sickened nearly 700 people in 19 states, and killed more than 40.
All of us who are concerned with pharmaceuticals have to follow and comply with different regulations and directives. In the last ten years number of do’s and don’ts and “how to” have increased. Competition for drugs and APIs from developing countries has increased.
The late, great Yankees player and coach Billy Martin was not known for holding his tongue. Through many seasons as the Yankees skipper, Martin had more than his fair share of arguments, ejections and fights with umpires and, of course, Yankees owner George Steinbrenner.
Another year has begun, and while I may struggle with my own healthful resolutions, I admire the resolve of those who strive to better understand the world around us.